We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATVI
101
DELISTED
Activision Blizzard
ATVI
| $108M | 0.22% |
1,158,504
-131,111
| -10% | -$12.3M |
|
|
PRAH
102
DELISTED
PRA Health Sciences, Inc.
PRAH
| $107M | 0.22% |
+700,000
| New | +$95.1M |
|
103
Goldman Sachs
GS
$312B
| $106M | 0.22% |
325,200
-9,200
| -3% | -$2.86M |
|
104
Otis Worldwide
OTIS
$27.9B
| $106M | 0.22% |
1,550,905
+601,050
| +63% | +$39.3M |
|
105
Booking.com
BKNG
$149B
| $106M | 0.22% |
1,132,500
-2,500
| -0.2% | -$222K |
|
106
Altria Group
MO
$113B
| $105M | 0.21% |
2,056,432
-10,100
| -0.5% | -$453K |
|
107
Lowe's Companies
LOW
$122B
| $105M | 0.21% |
551,527
-610,185
| -53% | -$105M |
|
108
Atea Pharmaceuticals
AVIR
$367M
| $105M | 0.21% |
1,694,419
| – | – |
|
109
Republic Services
RSG
$64.2B
| $104M | 0.21% |
1,045,272
+381,838
| +58% | +$35.8M |
|
|
CMA
110
DELISTED
Comerica
CMA
| $102M | 0.21% |
1,427,212
-223,550
| -14% | -$14.6M |
|
111
IBM
IBM
$219B
| $101M | 0.21% |
794,845
+48,430
| +6% | +$5.8M |
|
112
CACI
CACI
$11.5B
| $100M | 0.2% |
406,227
+121,317
| +43% | +$29M |
|
113
Jazz Pharmaceuticals
JAZZ
$16.3B
| $98.6M | 0.2% |
600,000
+285,000
| +90% | +$46.9M |
|
114
Parker-Hannifin
PH
$125B
| $98.3M | 0.2% |
311,655
+151,966
| +95% | +$43.9M |
|
115
Under Armour
UAA
$2.89B
| $98M | 0.2% |
4,421,305
-7,305,836
| -62% | -$153M |
|
116
Elevance Health
ELV
$82.7B
| $97.8M | 0.2% |
272,593
-3,500
| -1% | -$1.13M |
|
117
Blackrock
BLK
$176B
| $97.8M | 0.2% |
129,680
-2,800
| -2% | -$2.03M |
|
118
Lockheed Martin
LMT
$136B
| $97.6M | 0.2% |
264,167
+220,228
| +501% | +$75.6M |
|
119
Intuitive Surgical
ISRG
$129B
| $96.6M | 0.2% |
392,283
+45,450
| +13% | +$11.4M |
|
120
Capital One
COF
$136B
| $96.5M | 0.2% |
758,774
-672,311
| -47% | -$79.2M |
|
121
Hartford Financial Services
HIG
$38.9B
| $95.5M | 0.2% |
1,429,858
+440,375
| +45% | +$23.8M |
|
122
Cigna
CI
$73B
| $94.6M | 0.19% |
391,298
-9,900
| -2% | -$2.21M |
|
123
Olin
OLN
$2.17B
| $93.8M | 0.19% |
2,469,782
+200,000
| +9% | +$6.06M |
|
124
Prologis
PLD
$131B
| $93.5M | 0.19% |
881,925
+20,058
| +2% | +$2.04M |
|
125
Dover
DOV
$28.3B
| $92M | 0.19% |
671,147
-1,348,919
| -67% | -$172M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.